D J. Betteridge

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Diabetogenic Action of Statins: Mechanisms.

Diabetogenic Action of Statins: Mechanisms.

Journal: Current atherosclerosis reports

Published: May 01, 2019

Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.

Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.

Journal: Atherosclerosis

Published: February 05, 2018

Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.

Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.

Journal: International journal of cardiology

Published: May 25, 2016

The diabetogenic action of statins - mechanisms and clinical implications.

The diabetogenic action of statins - mechanisms and clinical implications.

Journal: Nature reviews. Endocrinology

Published: December 16, 2015

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).

Journal: Diabetologia

Published: August 26, 2015

Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.

Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.

Journal: PloS one

Published: March 31, 2015

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.

Journal: Diabetologia

Published: November 24, 2014

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

Journal: Atherosclerosis. Supplements

Published: May 21, 2014

LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.

LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.

Journal: Diabetes care

Published: April 12, 2014

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.

Journal: Journal of the American College of Cardiology

Published: November 03, 2013

CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients.

CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients.

Journal: Journal of lipid research

Published: October 10, 2013

Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary

Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis

Published: September 04, 2013

Showing 1-12 of 33

Last Updated: 09/26/2026